| 10/28/25 |
Merck & Co (MRK) |
Welireg for Renal Cell Cancer (RCC) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 10/28/25 |
Eisai (4523) |
Lenvima for Renal Cell Cancer (RCC) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 10/27/25 |
Hanmi Pharmaceutical (A008930) |
efpeglenatide for Obesity |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 10/26/25 |
Eli Lilly (LLY) |
Xinermei for Diabetes Mellitus, Type II |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 10/24/25 |
Acelyrin (SLRN) |
Izokibep for Psoriatic Arthritis (PsA) |
Subscribers Only |
Subscribers Only |
Subscribers Only |